A new feature at The Telegraph explores the limitations and constraints of Egypt’s “Two is Enough,” campaign, which aims to slow down rapid population growth in Egypt.
The Population Council and partners are expanding the implementation of Biruh Tesfa, an evidence-based program conceptualized by the Population Council to reduce the social isolation of vulnerable girls in urban Ethiopia, to reach girls living in forced domestic servitude, girls who are trafficked, as well as girls living with disabilities in Ethiopia.
In a live radio interview with KUMD-FM in Duluth, Minnesota, Senior Associate and enrolled citizen of the Cherokee Nation Kelly Hallman speaks about IMAGEN – the Indigenous Adolescent Girls’ Empowerment Network – a new evidenced-based, scalable program in the United Stated designed to address the realities of excluded Native American girls and young women in the US.
At the Stanford Social Innovation Review, Council researchers and Miriam Temin, Sajeda Amin, Thoai Ngo, and Stephanie Psaki unveiled a practical framework for designing and implementing programs that center around girls’ diverse needs, address multiple determinants of risk, and empower girls and improve their lives.
Much-anticipated results from the first in-human clinical trials of griffithsin, a naturally occurring anti-HIV protein, were presented at the HIV Research for Prevention (HIV R4P) conference in Madrid this October. These results, and research to date, suggest that it may be possible to formulate an on-demand user-controlled technology to prevent HIV and other STIs with limited risk of cross resistance.
We asked Tom Zydowsky, director of biomedical research and pharmaceutical development in the HIV and AIDS program at the Population Council’s Center for Biomedical Research (CBR) a few questions about griffithsin and its potential as a non-antiretroviral microbicide.
(November 28, 2018) NEW YORK, NY – The Population Council, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Los Angeles Biomedical Research Institute, and University of Washington School of Medicine today announced the launch of the first clinical trial to test the safety and efficacy of a gel for men to prevent unintended pregnancy. Three trial sites in the U.S. are now enrolling couples.